Medipex helps to open the Gateway to the UK Health Market

30 September 2026

Medipex is offering its services to international companies who are interested in the UK healthcare market.

The UK healthcare system remains an attractive entry point for global health innovation. However, it is highly competitive to get into this market (particularly the NHS). It is therefore essential that innovative companies understand where in the system their product or service could deliver the most benefits, what evidence the key decision makers will be looking for, and which of the multiple potential routes to adoption is the most appropriate. 

Moreover, the data shows that international exporters experience hurdles when attempting to access localised NHS procurement frameworks and establish necessary local evidence [1] [2]. International startups may be highly successful at clinical development in their home market, but they rarely have the local UK data, health economics models, or direct insights into NHS procurement needed to expand in the UK.

Whether you’re evaluating market fit, designing your route to adoption, or building your UK partnership strategy, our team can provide on-the-ground intelligence to de-risk your market entry strategy. The obtained information can help businesses to determine if the UK market is right for them and will help to design and test innovative products in the right way to streamline future adoption.

We can help you with:

• Market size: Explore if the UK/European market is right for your innovation, and review market size and trends
• Route to market: Understand how your innovation could fit into existing healthcare pathways, procurement, commissioning, and the potential barriers to adoption
• Value proposition: Evaluate the competitive landscape in terms of product benefits and features to help clarify the value proposition of your offering
• Validate unmet need: Facilitate access to feedback from relevant NHS staff to validate unmet needs and review the appetite for potential solutions to those needs
• IP review: Review the intellectual property (IP) landscape to evaluate patentability and freedom to operate for an idea, and develop IP protection strategies
• Health economic analysis: Model the potential cost savings for the healthcare service if your innovation is implemented, to help attract customers and partners
• Potential partners: Identify stakeholders who can support bringing your innovation to the UK market

 

This offer from Medipex to explore the UK market will also support the ambitions of our collaborators around the region, including West Yorkshire Combined Authority, Medilink and Heath Innovation Yorkshire and Humber, in attracting international healthtech to find a new home in West Yorkshire.

References:

[1] UCLPartners State of the Nation Report

[2] International Trade Administration United Kingdom MedTech Profile

 

Image generated by AI.